Clinical trial

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NCT02907372

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-11-01

PhaseNA

Study timeline

Study start (actual)2016-11-01Date precision: month

Registry last updated2023-01-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancer (CRPCa)unresolved

Interventions

neuropsychologic evaluationOTHER

oncogeriatric evaluationOTHER

Sponsors & collaborators

Centre Francois Baclesselead sponsor

National Cancer Institute, Francecollaborator

Mapped research locations

MontpellierFrance1 CaenFrance1 VillejuifFrance1 RouenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02907372 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.